150 related articles for article (PubMed ID: 1438973)
1. Neuropeptide Y 16-36 inhibits mucociliary activity but does not affect blood flow in the rabbit maxillary sinus in vivo.
Cervin A
Regul Pept; 1992 Jun; 39(2-3):237-46. PubMed ID: 1438973
[TBL] [Abstract][Full Text] [Related]
2. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
4. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
Palea S; Corsi M; Rimland JM; Trist DG
Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
6. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
7. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
[TBL] [Abstract][Full Text] [Related]
8. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
Lacroix JS; Ulman LG; Potter EK
Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
10. The effect of neuropeptide Y on mucociliary activity in the rabbit maxillary sinus.
Cervin A; Lindberg S; Mercke U
Acta Otolaryngol; 1991; 111(5):960-6. PubMed ID: 1684689
[TBL] [Abstract][Full Text] [Related]
11. Effects of neuropeptide Y and agonists selective for neuropeptide Y receptor sub-types on arterioles of the guinea-pig small intestine and the rat brain.
Xia J; Neild TO; Kotecha N
Br J Pharmacol; 1992 Nov; 107(3):771-6. PubMed ID: 1472974
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y in the rabbit maxillary sinus modulates cholinergic acceleration of mucociliary activity.
Cervin A; Lindberg S; Mercke U; Uddman R
Acta Otolaryngol; 1992 Sep; 112(5):872-81. PubMed ID: 1456044
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
Monnet FP; Fournier A; Debonnel G; de Montigny C
J Pharmacol Exp Ther; 1992 Dec; 263(3):1212-8. PubMed ID: 1469629
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
Grundemar L
Regul Pept; 1997 Aug; 71(2):97-101. PubMed ID: 9416991
[TBL] [Abstract][Full Text] [Related]
15. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
Misra S; Mahavadi S; Grider JR; Murthy KS
Regul Pept; 2005 Feb; 125(1-3):163-72. PubMed ID: 15582728
[TBL] [Abstract][Full Text] [Related]
17. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
[TBL] [Abstract][Full Text] [Related]
18. In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa.
Bernet F; Maubert E; Bernard J; Montel V; Dupouy JP
Regul Pept; 1994 Aug; 52(3):187-93. PubMed ID: 7800851
[TBL] [Abstract][Full Text] [Related]
19. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive effects of neuropeptide Y and related peptides in mice.
Broqua P; Wettstein JG; Rocher MN; Gauthier-Martin B; Riviere PJ; Junien JL; Dahl SG
Brain Res; 1996 Jun; 724(1):25-32. PubMed ID: 8816252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
